| Spirig HealthCare AG - Abirateron Spirig HC 250 mg, Filmtabletten | | 68141 | | 01 | | Abirateron Spirig HC 250 mg | | Filmtabletten | | L02BX03 | | Abiraterone | | 20.10.2021 | | |
| | Composition | | abirateroni acetas 250.00 mg corresp. abirateronum 223 mg, carmellosum natricum conexum, natrii laurilsulfas, povidonum K 30, cellulosum microcristallinum, lactosum monohydricum 34.00 mg, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, macrogolum 3350, talcum, pro compresso obducto corresp. natrium 5.3 mg. | | Packungsbestandteile | | Coated tablets | | | | Active Agent | Dose |
|---|
| Abirateroni Acetas | 250 mg correspond Abirateronum 223 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | Lactose Monohydrate | 34 mg | | | Macrogol | 3350 | | | Magnesii Stearas | | | | Natrii Laurilsulfas | | | | Poly(Alcohol Vinylicus) | | Überzug | | Povidonum K | 30 | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 56 | PR | PR | B | | Yes |
|
|
